drugset / Trial / NCT01631487
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39439335 in Healthy Japanese and Caucasian Adult Male Participants
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics of JNJ-39439335 in healthy Japanese and Caucasian adult male participants in Part 1, and in healthy Japanese adult male participants in Part 2.
Timeline
- Start
- 2012-07
- Primary completion
- 2013-03
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MAVATREP | Small molecule | 10 mg | Oral |
| Subject | MAVATREP | Small molecule | 25 mg | Oral |
| Subject | MAVATREP | Small molecule | 50 mg | Oral |
Indications
No indication recorded.